首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1623495

骨骼生長刺激器市場規模（按產品、應用、最終用戶、地區、範圍和預測）

Bone Growth Stimulator Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast

出版日期: 2024年08月27日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

骨骼生長刺激劑的市場規模及預測

骨骼生長刺激器市場規模預計在 2023 年價值 13.6 億美元，到 2031 年將達到 21.7 億美元，2024 年至 2031 年的複合年增長率為 5.99%。骨骼生長刺激器是一種有助於骨骼修復和生長的醫療設備。它產生低水平電磁場和聲波來刺激骨細胞，促進骨骼的生長和修復。此技術廣泛應用於骨科醫學，幫助骨折癒合，特別是癒合緩慢的骨折和不癒合的骨折，即骨骼無法正常癒合。骨骼生長刺激器也用於脊椎融合手術以加速癒合過程，並用於治療骨質疏鬆症和骨關節炎以強化骨骼和緩解症狀。

此外，骨骼生長刺激劑在加速骨折和疾病患者的癒合和改善預後方面發揮重要作用。

骨骼生長刺激器的全球市場動態

影響骨骼生長刺激器市場的關鍵市場動態

主要市場驅動因子

骨骼相關疾病的發生率不斷上升：

骨質疏鬆症、骨折和其他骨骼相關疾病的發生率不斷上升是骨骼生長刺激劑產業發展的主要推動因素。預計全球人口老化將推動市場成長，對改善骨癒合和再生的有效治療的需求也將推動市場成長。

骨骼生長刺激器的技術進步：

骨骼生長刺激器的技術進步，包括便攜式、非侵入性選擇，使得治療更容易獲得且更有效。這些技術創新改善了患者的治療效果和便利性，吸引了更多的使用者並促進了市場發展。

越來越人選擇非手術治療方案：

越來越多的患者和醫療保健提供者傾向於非手術治療，因為與手術治療相比，非手術治療風險更小、成本更低。骨骼生長刺激器提供了一種非侵入性替代方法，從而提高了其普及度和市場需求。

政府支持政策及報銷情況：

政府努力改善醫療保健基礎設施，並制定有利於骨骼生長刺激藥物的報銷規則，使得這些治療更便宜、更容易獲得。這種監管支持鼓勵了骨骼生長刺激劑的使用，從而促進了市場成長。

主要問題

設備及治療費用高：

骨骼生長刺激器的高成本（包括初始購買和持續使用）限制了市場擴張。這些高昂的成本限制了保險不足的患者和居住在低收入地區的患者獲得治療的機會，從而降低了市場滲透率。

認識與理解有限：

潛在消費者和某些醫療保健提供者並不知道骨骼生長刺激劑的益處和用途。這種數位落差導致採用率低並限制了市場擴張，因為人們不會尋求或推薦這些治療方案。

競爭性替代療法：

藥物、手術技術和其他非侵入性治療與骨骼生長刺激劑競爭。這些替代療法的可用性影響了患者和提供者的偏好，並限制了骨骼生長刺激劑的使用。

主要趨勢：

智慧科技整合：

骨骼生長刺激器市場正在轉向使用物聯網和人工智慧等智慧技術來改善設備功能和患者監測。這些技術提供個人化的治療方案和即時數據跟蹤，以改善患者的治療效果和參與度。

穿戴式和可攜式裝置的興起：

開發可穿戴、可攜式骨骼生長刺激器的趨勢日益增長。這些設備可以在您舒適的家中使用，同時保持治療效果，從而吸引廣大尋求非侵入性、靈活治療方案的患者。

注重研究與發展：

不斷增加的研發投入正在加速開發更有效率、更有效的骨骼生長刺激劑。這一趨勢正在帶來聯合療法和新刺激技術等突破，推動產業發展並提供更好的治療選擇。

對非侵入性治療的需求不斷增加：

隨著患者和醫療保健專業人員尋求侵入性較小、風險較低的治療方法，對非侵入性骨骼生長刺激器的需求日益增加。這一趨勢反映了醫療保健領域向微創治療的更廣泛轉變，骨骼生長刺激器成為骨骼癒合和再生的最佳選擇。

Bone Growth Stimulator Market size was valued at USD 1.36 Billion in 2023 and is projected to reach USD 2.17 Billion by 2031, growing at a CAGR of 5.99% from 2024 to 2031. A bone growth stimulator is a medical device that helps bones mend and grow. It works by generating low-level electromagnetic fields or acoustic waves that stimulate bone cells, causing them to grow and mend. This technology is widely utilized in orthopedic medicine to aid in the healing of fractures, particularly slow-healing or non-union fractures, in which bones fail to mend properly. Bone growth stimulators are also used in spinal fusion procedures to speed up the healing process, as well as in the treatment of osteoporosis and osteoarthritis to strengthen bones and relieve symptoms.

Furthermore, bone growth stimulators serve an important role in expediting healing and improving outcomes for patients suffering from bone fractures or diseases.

Global Bone Growth Stimulator Market Dynamics

The key market dynamics that are shaping the bone growth stimulator market include:

Key Market Drivers

Increasing Prevalence of Bone-Related Disorders:

The increasing prevalence of osteoporosis, fractures, and other bone-related disorders is a major driver of the bone growth stimulator industry. As the world's population ages, the demand for effective treatments to improve bone healing and regeneration rises is expected to drive market growth.

Technological Advancements in Bone Growth Stimulators:

Technological advancements in bone growth stimulators, such as portable and non-invasive choices, have made treatment more accessible and effective. These innovations improve patient outcomes and ease, attracting more users and driving market development.

Growing Preference for Non-Surgical Treatment Options:

Patients and healthcare providers are increasingly preferring non-surgical therapies since they are less risky and less expensive than surgical methods. Bone growth stimulators provide a non-invasive alternative, which boosts their popularity and market demand.

Supportive Government Policies and Reimbursement Scenario:

Government efforts to improve healthcare infrastructure, together with favorable reimbursement rules for bone growth stimulation medicines, have made these therapies more inexpensive and accessible. This regulatory support promotes the use of bone growth stimulators, which drives market growth.

Key Challenges:

High Cost of Devices and Treatment:

The high cost of bone growth stimulators, including initial purchase and continued usage, limits market expansion. This high cost restricts access for patients without adequate insurance coverage or those living in low-income areas, reducing market penetration.

Limited Awareness and Understanding:

Potential consumers and certain healthcare providers are unaware of the benefits and applications of bone growth stimulators. This information gap reduces the adoption rate since people may not seek out or recommend these treatment choices, limiting market expansion.

Competition from Alternative Treatment Options:

Pharmaceuticals, surgical techniques, and other non-invasive therapies compete with bone growth stimulators. The availability of these alternatives influences patient and provider preferences, which limits the use of bone growth stimulators.

Key Trends:

Integration of Smart Technologies:

The bone growth stimulator market is experiencing a shift towards the use of smart technologies like IoT and AI to improve device functionality and patient monitoring. These technologies offer personalized treatment regimens and real-time data tracking, which improves patient results and participation.

Expansion of Wearable and Portable Devices:

There is a growing trend in developing wearable and portable bone growth stimulators. These devices provide the comfort of home use while maintaining treatment efficacy, making them appealing to a broader patient demography looking for non-invasive and flexible treatment choices.

Focus on Research and Development:

Increased investment in R&D is accelerating the development of more efficient and effective bone growth stimulators. This trend is leading to breakthroughs such as combining therapies and novel stimulation techniques, which will advance the industry and provide better healing options.

Rising Demand for Non-Invasive Treatments:

As patients and healthcare professionals seek less intrusive and lower-risk treatment choices, the need for non-invasive bone growth stimulators is increasing. This trend reflects a broader change in healthcare towards minimally invasive therapies, with bone growth stimulators emerging as a top choice for bone healing and regeneration.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Bone Growth Stimulator Market Regional Analysis

Here is a more detailed regional analysis of the bone growth stimulator market:

North America:

According to Verified Market Research, North America is estimated to dominate the bone growth stimulator market during the forecast period. North America, particularly the United States, has a sophisticated healthcare system that places a significant focus on innovation and technological uptake. This environment promotes the development and early use of innovative medical devices, such as bone growth stimulators, which drives market expansion in the region.

The region has a high incidence of bone-related disorders such as osteoporosis and fractures, particularly among the elderly. This demographic trend raises the demand for effective bone healing therapies, making bone growth stimulators more popular.

Many top medical device companies and research institutions focused on the development of bone growth stimulators are based in North America. The region's market dominance is maintained by a strong concentration on R&D, backed up by large investment.

Furthermore, the United States, in particular, has advantageous healthcare payment rules that cover a wide range of treatments, including the usage of bone growth stimulators. These regulations make therapies more accessible to patients and stimulate the use of innovative medical equipment, which helps the industry grow in North America.

Asia Pacific:

Asia Pacific is experiencing a significant rise in the ageing population, particularly in Japan and China. This demographic transition increases the frequency of bone-related disorders such as osteoporosis and fractures, driving up demand for bone growth stimulators in the region

Many Asia Pacific countries are quickly expanding their healthcare infrastructure and boosting healthcare spending. This advancement increases access to innovative medical treatments and technology, such as bone growth stimulators, driving market growth.

Furthermore, economic expansion in the Asia Pacific region is resulting in greater healthcare investments from both governments and private enterprises. This financial assistance promotes the use of innovative medical equipment, such as bone growth stimulators, as part of larger initiatives to enhance healthcare results.

Europe:

Europe has a high rate of sports-related injuries and orthopedic surgeries due to active participation in sports and an ageing population. This increases the demand for effective rehabilitation and bone healing solutions, such as bone growth stimulators, to assure a speedy and complete recovery.

European countries have well-developed healthcare systems that provide complete coverage, including innovative medical devices. This makes bone growth stimulators more accessible to a wider spectrum of patients, boosting regional market growth.

Furthermore, in Europe, there is a rising preference for non-invasive treatment options over traditional surgical treatments due to their shorter recovery times and decreased risk of problems. This tendency encourages the use and market expansion of bone growth stimulators as a noninvasive therapeutic option.

Global Bone Growth Stimulator Market: Segmentation Analysis

The Bone Growth Stimulator Market is segmented based on Product, Application, End User and Geography.

Bone Growth Stimulator Market, By Product

Bone Growth Stimulation Devices
Bone Morphogenetic Proteins
Platelet-rich Plasma

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-rich Plasma. The bone growth stimulation devices segment is estimated to dominate the bone growth stimulator market due to a variety of causes, including the devices' wide range of applications in expediting fracture healing and promoting bone formation after surgery. Bone growth stimulation devices, which include both invasive and non-invasive technologies, are a diverse and effective alternative for patients looking to improve their bone health without undergoing additional procedures. Their ease of use, combined with the flexibility to be used in outpatient settings, contributes greatly to their appeal.

Bone Growth Stimulator Market, By Application

Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral & Maxillofacial Surgeries
Other Applications

Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. The spinal fusion surgeries segment is estimated to dominate the bone growth stimulator market during the forecast period due to the rising incidence of spinal illnesses, such as degenerative disc degeneration and spinal stenosis, particularly among the elderly. Spinal fusion surgery is a typical treatment for these problems, which aims to relieve pain and restore spinal stability. Bone growth stimulators are essential for accelerating bone healing after surgery, ensuring successful fusion and recovery. Their efficiency in improving surgical outcomes, combined with the increasing number of spinal fusion procedures conducted worldwide, boosts demand and market share for this application segment.

Bone Growth Stimulator Market, By End User

Hospitals and Ambulatory Surgical Centers
Home Care Settings
Academic and Research Institutes

Based on the End User, the bone growth stimulator market is divided into Hospitals & Ambulatory Surgical Centers, Home Care Settings, and Academic & Research Institutes. The hospitals and ambulatory surgical centers segment is estimated to dominate the market over the forecast period. The complex nature and severity of cases treated in these settings often require the use of modern medical equipment, such as bone growth stimulators, to ensure the best patient results. Hospitals and ambulatory surgical centres have the required infrastructure and qualified experts to deliver such treatments efficiently. Furthermore, these settings are more likely to be the first line of treatment for injuries and diseases that require bone development stimulation, such as fractures or operations.

Bone Growth Stimulator Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, the bone growth stimulator market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate during the forecasted period owing to the region's advanced healthcare infrastructure, a high frequency of bone-related disorders, significant R&D investments, and favourable healthcare legislation, such as extensive reimbursement schemes. The United States, in particular, plays an important role in driving the market due to its high healthcare spending, emphasis on breakthrough medical technology, and big ageing population that demands bone-related treatments.

Key Players

The "Bone Growth Stimulator Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Zimmer Biomet, Stryker Corporation, Johnson & Johnson, Ossur hf., B. Braun Melsungen AG, DJO Global, Arthrogenix, IEX Medical, EMS Physiotherapy Equipment Ltd., SONOSTAT, Alvar, SPIRE Corp., Stimulation Technologies, DJO Surgical, Donjoy and EBI Medical Products.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

In February 2024, Mainstay Medical announced a US$125 million equity financing transaction. This announcement shows a large investment in the bone growth stimulator field, which could indicate further market expansion and development.
In February 2024, Orthofix received FDA and CE Mark Approval for New Bone Growth Stimulants. This highlights regulatory approvals for new bone growth stimulators, highlighting prospective advances in technology and therapy choices.
In February 2024, SI-BONE, Inc., a corporation specializing in sacroiliac joint fusion with minimally invasive procedures, published financial results and guided 2024.

1 INTRODUCTION OF GLOBAL BONE GROWTH STIMULATOR MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BONE GROWTH STIMULATOR MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BONE GROWTH STIMULATOR MARKET, BY PRODUCT

5.1 Overview
5.2 Bone Growth Stimulation Devices
5.3 Bone Morphogenetic Proteins
5.4 Platelet-Rich Plasma

6 GLOBAL BONE GROWTH STIMULATOR MARKET, BY APPLICATION

6.1 Overview
6.2 Spinal Fusion Surgeries
6.3 Delayed Union & Nonunion Bone Fractures
6.4 Oral & Maxillofacial Surgeries
6.5 Others

7 GLOBAL BONE GROWTH STIMULATOR MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL BONE GROWTH STIMULATOR MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Arthrex, Inc.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Essex Woodlands Healthcare Partners (Bioventus LLC)
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Colfax Corporation (DJO Global, Inc)
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Isto Biologics
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Johnson & Johnson (Depuy Synthes)
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Medtronic Plc
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Orthofix Medical Inc.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Stryker Corporation
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Terumo Corporation
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Zimmer Biomet Holdings, Inc.
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments